Sorry, you need to enable JavaScript to visit this website.

Our Policies on Ethics

As we work to develop new medicines, our strict standards of moral and ethical conduct are guided by the help and oversight of institutional review boards, regulatory authorities, and industry association guidelines governing ethical clinical trial conduct and research integrity. Additionally, we have created our own agency to oversee our research ethics and integrity. 

All Pfizer-sponsored interventional studies are conducted in accordance with applicable laws and regulations, as well as principles derived from relevant international standards including: 

  • The Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines 

  • The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 guideline for Good Clinical Practice 

  • PhRMA’s Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results 

  • The Declaration of Helsinki 

  • The United States Belmont report 

We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving priorities.

Related Articles

Science & Innovation

How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile

When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.

BTS Pearl River colleagues thumbnail

Science & Innovation

Behind the Science: A New Path to Tackling Metastatic Breast Cancer

In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.

Jennifer, Pfizer thumbnail

Purpose & Ideals

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Friends walking in forest thumbnail

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site Details